Cresset Asset Management, LLC Fibrogen Inc Transaction History
Cresset Asset Management, LLC
- $17.3 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding FGEN
# of Institutions
78Shares Held
37.3MCall Options Held
351KPut Options Held
105K-
Armistice Capital, LLC New York, NY6.8MShares$2.11 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.88MShares$1.82 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA4.62MShares$1.43 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.91MShares$1.21 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.41MShares$746,9910.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $29.1M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...